New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

Start Comparing ETFs Now!

›ETF Issuers›Mirae Asset Global Investments›371470

371470

Mirae Asset TIGER Biotech Solactive ETF

Passive ETF Equity

Not rated

The 371470 Exchange Traded Fund (ETF) is provided by Mirae Asset Global Investments. It is built to track an index: Solactive China Biotech Index. The 371470 ETF provides physical exposure, so by buying it you actually own parts of all the 31 underlying holdings. This share class generates a stream of income by distributing dividends.

₩8,280

-₩40 (-0.48%) today

1:16 AM 08/05/26 Open

1D price range

₩8,280₩8,440

52W price range

₩7,431.42₩9,854.72

YTD Perf.

-2.87%

YTD Flows

Annualized volatility

Fund AuM

€27M

Share class AuM

€27M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

KR7371470006

TER

0.59%

Inception date

12/3/2020

Issuer

Mirae Asset Global Investments

Benchmark

Solactive China Biotech Index

Replication method

Dividend policy

Distributing

Compare similar ETFs

ETF Name	1w perf.
09820 Global X China Biotech ETF	-
KURE KraneShares MSCI All China Health Care Index ETF	-1.45%
510310 E Fund Seeded CSI 300 ETF	-3.28%
510500 China Southern CSI 500 Index ETF	-3.91%
159949 China Huaan SZSE Chinext 50 ETF	-8.61%
82828 Hang Seng China Enterprises Index ETF	+3.41%
ICGA iShares MSCI China UCITS ETF	+3.52%
CNYA iShares MSCI China A UCITS ETF	-3.03%
83188 ChinaAMC CSI 300 Index ETF	-3.32%
CTEC iShares MSCI China Tech UCITS ETF	+0.56%
XCHA Xtrackers CSI300 Swap UCITS ETF	-3.03%
82823 iShares FTSE A50 China Index ETF	-3.76%
FLXC Franklin FTSE China UCITS ETF	+3.31%
02801 iShares Core MSCI China ETF	+3.56%
LG9 Xtrackers MSCI China UCITS ETF	+3.54%

API

PerformanceDec 30, 2025 - Aug 3, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 06/30/26

Healthcare

94.68%

Unavailable

5.31%

Latest 371470 news

No content available for this fund

FAQ about 371470

371470 is a Passive ETF. This ETF provides exposure to Chinese Biotechnology Equities.

371470 tracks the Solactive China Biotech Index - CNY, through a optimized sampling replication method.

371470 carries a total expense ratio (TER) of 0.59%, indicating the annual cost for holding the fund.

371470 was introduced to the market on December 3, 2020. It trades on South Korea

Mirae Asset TIGER Biotech Solactive ETF, 371470, is provided by Mirae Asset Global Investments. Learn more about Mirae Asset Global Investments here.

371470 oversees €27M in assets as of August 3, 2026.

371470 follows a distributing dividend policy, meaning it pays out income to investors. As of August 3, 2026, its 12-month trailing yield was 0.73%.

As of June 30, 2026, 371470 has significant geographic allocations in China, Switzerland and Hong Kong.

As of June 30, 2026, 371470 focuses largely on Healthcare.

As of June 30, 2026, 371470 holds 31 positions in its portfolio, with 78.59% of assets concentrated in its top 15 holdings.

As of June 30, 2026, 371470 top three holdings include WuXi AppTec Co., Ltd., WuXi Biologics (Cayman), Inc. and BeOne Medicines Ltd..

The base currency of 371470 is KRW.

Top 10 holdings

Data as of 06/30/26

WuXi AppTec Co., Ltd.

13.16%

WuXi Biologics (Cayman), Inc.

9.59%

BeOne Medicines Ltd.

9.08%

Innovent Biologics, Inc.

8.91%

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

8.52%

Akeso, Inc.

5.63%

Sino Biopharmaceutical Ltd.

4.04%

Hansoh Pharmaceutical Group Co., Ltd.

3.36%

3SBio, Inc.

3.06%

Shanghai Allist Pharmaceuticals Co., Ltd.

2.66%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

The Ultimate ETF Comparison Tool - Try Now!

Mirae Asset TIGER Biotech Solactive ETF

FAQ about 371470

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US